| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/02/2023 | 14.92% | Piper Sandler | $150 → $165 | Maintains | Overweight |
| 08/03/2023 | 25.37% | Truist Securities | $170 → $180 | Maintains | Buy |
| 06/13/2023 | 0.29% | Piper Sandler | → $144 | Upgrades | Neutral → Overweight |
| 05/03/2023 | 14.22% | B of A Securities | $160 → $164 | Maintains | Buy |
| 04/05/2023 | -10.15% | Piper Sandler | $133 → $129 | Maintains | Neutral |
| 03/21/2023 | 5.86% | Keefe, Bruyette & Woods | → $152 | Upgrades | Market Perform → Outperform |
| 02/08/2023 | -7.37% | Piper Sandler | → $133 | Maintains | Neutral |
| 12/20/2022 | -7.37% | Piper Sandler | $144 → $133 | Maintains | Neutral |
| 11/21/2022 | 14.92% | Morgan Stanley | $215 → $165 | Maintains | Overweight |
| 11/03/2022 | 5.17% | Keefe, Bruyette & Woods | $199 → $151 | Downgrades | Outperform → Market Perform |
| 06/24/2022 | 28.85% | Piper Sandler | $205 → $185 | Downgrades | Overweight → Neutral |
| 03/28/2022 | 49.74% | Morgan Stanley | $197 → $215 | Maintains | Overweight |
| 02/14/2022 | 37.21% | Morgan Stanley | $191 → $197 | Maintains | Overweight |
| 11/04/2021 | 33.03% | Morgan Stanley | $184 → $191 | Maintains | Overweight |
| 10/15/2021 | 28.15% | Morgan Stanley | $190 → $184 | Maintains | Overweight |
| 10/14/2021 | 39.3% | Piper Sandler | → $200 | Initiates Coverage On | → Overweight |
| 08/16/2021 | 32.33% | Morgan Stanley | $188 → $190 | Maintains | Overweight |
| 07/23/2021 | — | William Blair | Initiates Coverage On | → Outperform | |
| 05/27/2021 | 30.94% | Morgan Stanley | $172 → $188 | Maintains | Overweight |
| 05/21/2021 | 44.17% | B of A Securities | → $207 | Initiates Coverage On | → Buy |
| 04/19/2021 | 28.85% | Truist Securities | $170 → $185 | Maintains | Buy |
| 01/12/2021 | 19.79% | Morgan Stanley | $155 → $172 | Maintains | Overweight |
| 11/24/2020 | 7.95% | Morgan Stanley | $143 → $155 | Maintains | Overweight |
| 08/19/2020 | -0.4% | Morgan Stanley | $140 → $143 | Maintains | Overweight |
| 08/10/2020 | -2.49% | Morgan Stanley | $128 → $140 | Maintains | Overweight |
| 06/11/2020 | -10.85% | Morgan Stanley | $125 → $128 | Maintains | Overweight |
| 05/18/2020 | -12.94% | Morgan Stanley | $131 → $125 | Maintains | Overweight |
| 05/07/2020 | 0.99% | SunTrust Robinson Humphrey | $155 → $145 | Maintains | Buy |
| 04/01/2020 | -8.76% | Morgan Stanley | $151 → $131 | Maintains | Overweight |
| 02/28/2020 | 5.17% | Morgan Stanley | $149 → $151 | Maintains | Overweight |
| 02/19/2020 | 10.04% | UBS | $152 → $158 | Maintains | Buy |
| 02/14/2020 | 3.77% | Morgan Stanley | $137 → $149 | Maintains | Overweight |
| 11/08/2019 | -4.58% | Morgan Stanley | $130 → $137 | Maintains | Overweight |
| 11/06/2019 | 5.86% | UBS | $154 → $152 | Maintains | Buy |
| 10/10/2019 | 7.26% | UBS | $153 → $154 | Maintains | Buy |
| 10/03/2019 | 0.99% | SunTrust Robinson Humphrey | $140 → $145 | Maintains | Buy |
| 09/10/2019 | 6.56% | UBS | $142 → $153 | Maintains | Buy |
| 09/09/2019 | 6.56% | UBS | $142 → $153 | Maintains | Buy |
| 08/15/2019 | -9.46% | Morgan Stanley | $119 → $130 | Maintains | Overweight |
What is the target price for Assurant (AIZ)?
The latest price target for Assurant (NYSE: AIZ) was reported by Piper Sandler on October 2, 2023. The analyst firm set a price target for $165.00 expecting AIZ to rise to within 12 months (a possible 14.92% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Assurant (AIZ)?
The latest analyst rating for Assurant (NYSE: AIZ) was provided by Piper Sandler, and Assurant maintained their overweight rating.
When is the next analyst rating going to be posted or updated for Assurant (AIZ)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Assurant, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Assurant was filed on October 2, 2023 so you should expect the next rating to be made available sometime around October 2, 2024.
Is the Analyst Rating Assurant (AIZ) correct?
While ratings are subjective and will change, the latest Assurant (AIZ) rating was a maintained with a price target of $150.00 to $165.00. The current price Assurant (AIZ) is trading at is $143.58, which is out of the analyst's predicted range.